vol2 - Page 163
Return to Index
106. The meetings, which began quietly, was a real eye
opener for me. Federal officials brought forward a number of
_probleme" with the GeorgAe program, Most of these "problems"
w_re manor poAnts which could be immedAately addressed. After
listing quietly, members _f the Georgia Patlent Review Board
began _kAng federal officlals pointed questions about when our
program would begin to receAve the marijuana we had been
promised. We wanted to know how long 4t would be before we could
provlde Georgia cancer patients with licit access to marijuana.
The agencies restated thel_ "new" position - Georgia would not
receive any mar_uana, only synthetic THC pills,
I07. After nearly an hou_ of back and forth conflict
.... the meeting became very intense and emotional. Federal officia!s
flatly told Representative Gingrlch ani_ members of the Georgia
Patient Review Board that Georgia wou!_ have to conform to
federal demands. They again stated the_ regardless of Georgia's
FDA approved IND calling for marijuanas Georgia would not be
gettAng marijuana, but would only _eceive synthetic THC0 THC is
a drug which federal agencies were pz, omotlng as a "replacement"
for marijuana, despite a ntunber of =tudles which showed oral THC
wee medAcally %n_er_o_ to marijuana and more likely to cause
adverse slde effects°
108. Ae a private citizen ! was not prepared for the
overreaching a_rogance of these federal off_cAals. Despite all
thelr past promisee _hey were takAng a different position and
Georgia cancer patients were being told to accept THC or nothln_.
_t was the final straw. The _eetlng broke up wAth considerable
Return to Index